Roberta Donadelli

ORCID: 0000-0003-1472-1143
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Complement system in diseases
  • Renal Diseases and Glomerulopathies
  • Blood groups and transfusion
  • Platelet Disorders and Treatments
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Blood Coagulation and Thrombosis Mechanisms
  • Iron Metabolism and Disorders
  • Adenosine and Purinergic Signaling
  • Chronic Kidney Disease and Diabetes
  • Immune Response and Inflammation
  • SARS-CoV-2 and COVID-19 Research
  • Advanced Glycation End Products research
  • Cell Adhesion Molecules Research
  • Pregnancy and preeclampsia studies
  • Renin-Angiotensin System Studies
  • Immune Cell Function and Interaction
  • Endoplasmic Reticulum Stress and Disease
  • Erythrocyte Function and Pathophysiology
  • COVID-19 Clinical Research Studies
  • Systemic Lupus Erythematosus Research
  • Nitric Oxide and Endothelin Effects
  • Macrophage Migration Inhibitory Factor
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • RNA Interference and Gene Delivery
  • Diabetes Treatment and Management

Mario Negri Institute for Pharmacological Research
2015-2024

Istituti di Ricovero e Cura a Carattere Scientifico
2014-2024

Scripps Research Institute
2004-2005

Radboud University Nijmegen
2002

Azienda Ospedaliero Universitaria Ospedali Riuniti
2000

Hemolytic uremic syndrome (HUS) is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal impairment. Most childhood cases are caused Shiga toxin-producing bacteria. The other form, atypical HUS (aHUS), accounts for 10% of has a poor prognosis. Genetic complement abnormalities have been found in aHUS.We screened 273 consecutive patients with aHUS studied their role predicting clinical phenotype response to treatment. We compared mutation frequencies localization...

10.2215/cjn.02210310 article EN Clinical Journal of the American Society of Nephrology 2010-07-02

Abstract In the present study, we examined hypothesis that dynamic characteristics of flow modulate production vasoactive mediators, namely nitric oxide (NO) and endothelin-1 (ET-1), by human umbilical vein endothelial cells (HUVECs). Cells were exposed for 6 hours in a cone-and-plate apparatus to different types flow: steady laminar, with shear stresses 2, 8, 12 dyne/cm 2 ; pulsatile stress from 8.2 16.6 frequency Hz; periodic square wave cycles 15 minutes 8 turbulent, on average. A second...

10.1161/01.res.76.4.536 article EN Circulation Research 1995-04-01

We addressed the role of hyperglycemia in leukocyte-endothelium interaction under flow conditions by exposing human umbilical vein endothelial cells for 24 h to normal (5 mM), high concentration glucose (30 advanced glycosylation end product-albumin (100 microg/ml), or hyperglycemic (174-316 mg/dl) sera from patients with diabetes and abnormal hemoglobin A1c (8.1+/-1.4%). At incubation were perfused total leukocyte suspension a parallel plate chamber laminar (1.5 dyn/cm2). Rolling adherent...

10.1172/jci656 article EN Journal of Clinical Investigation 1998-05-01

Focal segmental glomerulosclerosis is a kidney disease that manifested as the nephrotic syndrome. It often resistant to glucocorticoid therapy and progresses end-stage renal in 50 70% of patients. Genetic studies have shown familial focal podocytes, which are major components glomerular filtration barrier. However, molecular cause over half cases primary unknown, effective treatments been elusive.

10.1056/nejmoa1101273 article EN New England Journal of Medicine 2011-07-14

Atypical hemolytic uremic syndrome (aHUS) is a genetic ultrarare renal disease associated with overactivation of the alternative pathway complement. Four gain-of-function mutations that form hyperactive or deregulated C3 convertase have been identified in Factor B (FB) ligand binding sites. Here, we studied functional consequences 10 FB changes recently from different aHUS cohorts. Using several tests for and C5 formation regulation, two potentially disease-relevant formed either an...

10.1681/asn.2013070796 article EN Journal of the American Society of Nephrology 2014-03-21

Microvascular thrombosis is associated with multiorgan failure and mortality in coronavirus disease 2019 (COVID-19). Although thrombotic complications may be ascribed to the ability of SARS-CoV-2 infect replicate endothelial cells, it has been poorly investigated whether, complexity viral infection human host, specific elements alone can induce damage. Detection circulating spike protein sera severe COVID-19 patients was evaluated by ELISA.

10.3389/fimmu.2022.827146 article EN cc-by Frontiers in Immunology 2022-03-07

Glomerulopathy with fibronectin (FN) deposits (GFND) is an autosomal dominant disease age-related penetrance, characterized by proteinuria, microscopic hematuria, hypertension, and massive glomerular of FN that lead to end-stage renal failure. The genetic abnormality underlying GFND was still unknown. We hypothesized mutations in FN1, which encodes FN, were the cause GFND. In a large Italian pedigree eight affected subjects, we found linkage at FN1 locus 2q32. sequenced 15 unrelated...

10.1073/pnas.0707730105 article EN Proceedings of the National Academy of Sciences 2008-02-12

Thrombotic thrombocytopenic purpura is a rare disorder of small vessels that associated with deficiency the von Willebrand factor-cleaving protease ADAMTS13, which favors platelet adhesion and aggregation in microcirculation. The disease manifests mainly central nervous system symptoms, but cases renal insufficiency have been reported. Presented are findings genetic basis phenotype heterogeneity thrombotic two sisters within one family. patients had ADAMTS13 as result heterozygous mutations...

10.1681/asn.2005010086 article EN Journal of the American Society of Nephrology 2005-03-31

Investigated was the effect of high albumin concentrations on proximal tubular cell expression fractalkine. Human cells (HK-2) were incubated with human serum (HSA), which induced a dose-dependent increase in fractalkine mRNA associated increased levels both membrane-bound and soluble forms protein. To evaluate role nuclear factor kappaB (NF-kappaB) activation HSA-induced mRNA, HK-2 infected recombinant adenovirus encoding natural inhibitor NF-kappaB, IkBalpha; 43% reduction resulted....

10.1097/01.asn.0000089564.55411.7f article EN Journal of the American Society of Nephrology 2003-10-01

Abstract von Willebrand factor (VWF), a multimeric protein with central role in hemostasis, has been shown to interact complement components. However, results are contrasting and inconclusive. By studying 20 patients congenital thrombotic thrombocytopenic purpura (cTTP) who cannot cleave VWF multimers because of genetic ADAMTS13 deficiency, we investigated the mechanism through which modulates its pathophysiological implications for human diseases. Using assays ex vivo serum-induced C3 C5b-9...

10.4049/jimmunol.1601121 article EN The Journal of Immunology 2017-06-27

Genetic and acquired abnormalities causing dysregulation of the complement alternative pathway contribute to atypical hemolytic uremic syndrome (aHUS), a rare disorder characterized by thrombocytopenia, nonimmune microangiopathic anemia, acute kidney failure. However, in substantial proportion patients disease-associated alterations are still unknown.Whole-exome whole-genome sequencing were performed two unrelated families with infantile recessive aHUS. Sequencing cDNA from affected...

10.2215/cjn.08520814 article EN Clinical Journal of the American Society of Nephrology 2015-04-09

Membranoproliferative glomerulonephritis (MPGN) was recently classified as C3 glomerulopathies (C3G), and immune-complex (IC) mediated MPGN. Dysregulation of the complement alternative pathway, driven by acquired and/or genetic defects, plays a pathogenetic role in C3G. However, pathway abnormalities were also found IC-MPGN. The most common drivers are nephritic factors (C3NeFs), heterogeneous autoantibodies that stabilize convertase, C3bBb. C3NeFs traditionally detected hemolytic assays...

10.3389/fimmu.2018.02329 article EN cc-by Frontiers in Immunology 2018-10-15

Background Complement activation contributes to lung dysfunction in coronavirus disease 2019 (COVID-19). We assessed whether C5 blockade with eculizumab could improve outcome. Methods In this single-centre, academic, unblinded study two 900 mg doses were added-on standard therapy ten COVID-19 patients admitted from February 2020 April and receiving Continuous-Positive-Airway-Pressure (CPAP) ventilator support ≤24 hours. compared their outcomes those of 65 contemporary similar controls....

10.1371/journal.pone.0261113 article EN cc-by PLoS ONE 2021-12-20

We have previously documented that cyclosporine exerts a direct cytotoxic effect on endothelial cells and causes an increase in renal vascular resistance (RVR) the rat. In present study we investigated whether FK506, novel immunosuppressive agent thought to be less nephrotoxic than CsA, impairs cell function vitro affects RVR vivo. eicosanoid release endothelin were measured bovine aortic culture exposed for 1, 6, 24 hr increasing concentrations of FK506 (1 nM 10 μM) or CsA (0.5, μM). No...

10.1097/00007890-199211000-00002 article EN Transplantation 1992-11-01
Coming Soon ...